125 related articles for article (PubMed ID: 22589409)
21. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.
Monge M; Colas E; Doll A; Gonzalez M; Gil-Moreno A; Planaguma J; Quiles M; Arbos MA; Garcia A; Castellvi J; Llaurado M; Rigau M; Alazzouzi H; Xercavins J; Alameda F; Reventos J; Abal M
Cancer Res; 2007 Jul; 67(14):6753-9. PubMed ID: 17638886
[TBL] [Abstract][Full Text] [Related]
22. Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis.
Chan DW; Yu SY; Chiu PM; Yao KM; Liu VW; Cheung AN; Ngan HY
J Pathol; 2008 Jul; 215(3):245-52. PubMed ID: 18464245
[TBL] [Abstract][Full Text] [Related]
23. Tumor promoting properties of the ETS protein MEF in ovarian cancer.
Yao JJ; Liu Y; Lacorazza HD; Soslow RA; Scandura JM; Nimer SD; Hedvat CV
Oncogene; 2007 Jun; 26(27):4032-7. PubMed ID: 17213815
[TBL] [Abstract][Full Text] [Related]
24. ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.
Colas E; Muinelo-Romay L; Alonso-Alconada L; Llaurado M; Monge M; Barbazan J; Gonzalez M; Schoumacher M; Pedrola N; Ertekin T; Devis L; Ruiz A; Castellvi J; Doll A; Gil-Moreno A; Vazquez-Levin M; Lapyckyj L; Lopez-Lopez R; Robine S; Friederich E; Castro M; Reventos J; Vignjevic D; Abal M
Oncogene; 2012 Nov; 31(45):4778-88. PubMed ID: 22266854
[TBL] [Abstract][Full Text] [Related]
25. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
Yamamura S; Matsumura N; Mandai M; Huang Z; Oura T; Baba T; Hamanishi J; Yamaguchi K; Kang HS; Okamoto T; Abiko K; Mori S; Murphy SK; Konishi I
Int J Cancer; 2012 Jan; 130(1):20-8. PubMed ID: 21503873
[TBL] [Abstract][Full Text] [Related]
26. Forkhead-box R2 promotes metastasis and growth by stimulating angiogenesis and activating hedgehog signaling pathway in ovarian cancer.
Li B; Huang W; Cao N; Lou G
J Cell Biochem; 2018 Sep; 119(9):7780-7789. PubMed ID: 29943836
[TBL] [Abstract][Full Text] [Related]
27. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes.
Tan Y; Raychaudhuri P; Costa RH
Mol Cell Biol; 2007 Feb; 27(3):1007-16. PubMed ID: 17101782
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis.
Chen PM; Cheng YW; Wang YC; Wu TC; Chen CY; Lee H
Neoplasia; 2014 Nov; 16(11):961-71. PubMed ID: 25425970
[TBL] [Abstract][Full Text] [Related]
29. FOXM1 expression mediates growth suppression during terminal differentiation of HO-1 human metastatic melanoma cells.
Huynh KM; Soh JW; Dash R; Sarkar D; Fisher PB; Kang D
J Cell Physiol; 2011 Jan; 226(1):194-204. PubMed ID: 20658516
[TBL] [Abstract][Full Text] [Related]
30. FoxM1 regulates Sirt1 expression in glioma cells.
Zhu GY; Shi BZ; Li Y
Eur Rev Med Pharmacol Sci; 2014; 18(2):205-11. PubMed ID: 24488909
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
[TBL] [Abstract][Full Text] [Related]
32. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress.
Monge M; Colas E; Doll A; Gil-Moreno A; Castellvi J; Diaz B; Gonzalez M; Lopez-Lopez R; Xercavins J; Carreras R; Alameda F; Canals F; Gabrielli F; Reventos J; Abal M
Carcinogenesis; 2009 Aug; 30(8):1288-97. PubMed ID: 19443906
[TBL] [Abstract][Full Text] [Related]
33. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
[TBL] [Abstract][Full Text] [Related]
34. C-terminus-deleted FoxM1 is expressed in cancer cell lines and induces chromosome instability.
Kim YH; Choi MH; Kim JH; Lim IK; Park TJ
Carcinogenesis; 2013 Aug; 34(8):1907-17. PubMed ID: 23615399
[TBL] [Abstract][Full Text] [Related]
35. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes.
Mizuno T; Murakami H; Fujii M; Ishiguro F; Tanaka I; Kondo Y; Akatsuka S; Toyokuni S; Yokoi K; Osada H; Sekido Y
Oncogene; 2012 Dec; 31(49):5117-22. PubMed ID: 22286761
[TBL] [Abstract][Full Text] [Related]
36. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
[TBL] [Abstract][Full Text] [Related]
37. Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic.
Liu Y; Hock JM; Van Beneden RJ; Li X
Mol Carcinog; 2014 May; 53(5):380-91. PubMed ID: 23255470
[TBL] [Abstract][Full Text] [Related]
38. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
[TBL] [Abstract][Full Text] [Related]
39. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
40. Co-regulation and function of
Barger CJ; Chee L; Albahrani M; Munoz-Trujillo C; Boghean L; Branick C; Odunsi K; Drapkin R; Zou L; Karpf AR
Elife; 2021 Apr; 10():. PubMed ID: 33890574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
